间质细胞
免疫系统
疾病
免疫学
生物
免疫耐受
医学
癌症研究
病理
作者
Susan Westfall,Maria E. Gentile,Tayla M. Olsen,Danielle Karo‐Atar,Andrei Bogza,Franziska Röstel,Ryan D. Pardy,Giordano Mandato,Ghislaine Fontès,De’Broski R. Herbert,Heather J. Melichar,Valérie Abadie,Martin J. Richer,Donald C. Vinh,Joshua F. E. Koenig,Oliver J. Harrison,Maziar Divangahi,Sebastian Weis,Alex Gregorieff,Irah L. King
出处
期刊:
[Cold Spring Harbor Laboratory]
日期:2024-09-08
标识
DOI:10.1101/2024.09.04.611190
摘要
SUMMARY Type 1 immunity mediates host defense through pathogen elimination, but whether this pathway also impacts tissue function is unknown. Here we demonstrate that rapid induction of IFNγ signaling coordinates a multi-cellular response that is critical to limit tissue damage and maintain gut motility following infection of mice with a tissue-invasive helminth. IFNγ production is initiated by antigen-independent activation of lamina propria CD8 + T cells following MyD88-dependent recognition of the microbiota during helminth-induced barrier invasion. IFNγ acted directly on intestinal stromal cells to recruit neutrophils that limited parasite-induced tissue injury. IFNγ sensing also limited the expansion of smooth muscle actin-expressing cells to prevent pathological gut dysmotility. Importantly, this tissue-protective response had limited impact on parasite burden, indicating that IFNγ supports a disease tolerance defense strategy. Our results have important implications for managing the pathophysiological sequelae of post-infectious gut dysfunction and chronic inflammatory diseases associated with stromal remodelling. HIGHLIGHTS Type 1 immunity is required for disease tolerance to tissue-invasive infection. Gut-resident CD8 + T cells produce IFNγ in an antigen-independent, yet microbiota-dependent manner. IFNγ signaling recruits neutrophils in a cell-extrinsic manner to limit helminth-induced tissue injury. Direct sensing of IFNγ by intestinal stroma is essential to limit tissue damage and maintain gut motility during infection.
科研通智能强力驱动
Strongly Powered by AbleSci AI